obesity drugs

Make a delay and accumulation of outstanding tasks Full stop
Biotech

Terns mothballs obesity program after phase 2 data fall short

The phase 2 trial delivered a mix of weight loss and tolerability that fell short of expectations and evidence the asset causes liver injuries.
Nick Paul Taylor Oct 22, 2025 7:15am
Measuring tape on top of cash

Kailera raises hefty $600M to take Zepbound rival into ph. 3

Oct 14, 2025 9:20am
weight loss drugs obesity

Skye's CB1 blocker fails to reduce weight in obesity study

Oct 6, 2025 7:55am
weight loss scale weigh measure tape obesity overweight

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

Sep 30, 2025 6:40am
cancel

Lilly withdraws phase 2 obesity trial before starting enrollment

Sep 25, 2025 8:07am
Measuring tape on top of cash

Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline

Sep 22, 2025 7:47am